Search Results 91-100 of 11337 for MOTS-c Analogue
2024 Oct; 39 (10):2621-2626 Epub 2024 June 07. View PubMed; Karau MJ, Alarcon Perico D, Guarin Perez SF, Koscianski C, Abdel MP, Patel R, Bedard NA. Duration ...
The purpose of this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory ...
The purpose of this study is to evaluate the change from baseline in systolic blood pressure (SBP) by automated office blood pressure monitoring (AOBPM), with ...
... analogs like calcitriol, to ... A Study to Evaluate Preemptive Therapy in Hepatitis C Organ Transplant Recipients Scottsdale/Phoenix, AZ; Jacksonville, FL.
Goyal A, Layman AJ, Bois MC, Maleszewski JJ. Characteristics of Lambl excrescences of aortic and pulmonary valves in healthy hearts. Cardiovasc Pathol. 2024 Jan ...
Making an abnormal version of the AAT protein can result in liver disease as Z-AAT builds up in liver cells, which leads to liver problems such as liver ...
have to wait until 9/1 to submit CCaTS Prog. App. Submit Degree Program Form, Master's. Thesis Advisory Committee Approval Form, and Protocol by 5/1. OBG 6840 ...
SYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psychometric validation study of the PAH-SYMPACT, a new quality of life questionnaire ...
Confirmed decompensated cirrhosis (defined as Child Pugh class B or C) or concern for shock liver (AST > 1000U/L or total Bilirubin > 5.0mg/dl) at enrollment;.
Eligibility last updated 9/9/2024. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.